<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4">
    <!--The publisher of this article does not allow downloading of the full text in XML form.-->
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">Science</journal-id>
        <journal-id journal-id-type="iso-abbrev">Science</journal-id>
        <journal-id journal-id-type="pmc-domain-id">319</journal-id>
        <journal-id journal-id-type="pmc-domain">nihpa</journal-id>
        <journal-title-group>
          <journal-title>Science (New York, N.Y.)</journal-title>
        </journal-title-group>
        <issn pub-type="ppub">0036-8075</issn>
        <issn pub-type="epub">1095-9203</issn>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-is-collection-domain</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-collection-title</meta-name>
            <meta-value>NIHPA Author Manuscripts</meta-value>
          </custom-meta>
        </custom-meta-group>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC9299269</article-id>
        <article-id pub-id-type="pmcid-ver">PMC9299269.1</article-id>
        <article-id pub-id-type="pmcaid">9299269</article-id>
        <article-id pub-id-type="pmcaiid">9299269</article-id>
        <article-id pub-id-type="manuscript-id">NIHMS1818940</article-id>
        <article-id pub-id-type="pmid">35617398</article-id>
        <article-id pub-id-type="doi">10.1126/science.abe1505</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHMS1818940</article-id>
        <article-id pub-id-type="manuscript-id-alternative">NIHPA1818940</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="heading">
            <subject>Article</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets</article-title>
        </title-group>
        <contrib-group>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Tang</surname>
              <given-names initials="F">Fanying</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="FN4" ref-type="author-notes">*</xref>
            <xref rid="FN1" ref-type="author-notes">#</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Xu</surname>
              <given-names initials="D">Duo</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="FN4" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wang</surname>
              <given-names initials="S">Shangqian</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A6" ref-type="aff">6</xref>
            <xref rid="FN4" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Wong</surname>
              <given-names initials="CK">Chen Khuan</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="FN4" ref-type="author-notes">*</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Martinez-Fundichely</surname>
              <given-names initials="A">Alexander</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Lee</surname>
              <given-names initials="CJ">Cindy J.</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Cohen</surname>
              <given-names initials="S">Sandra</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Park</surname>
              <given-names initials="J">Jane</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Hill</surname>
              <given-names initials="CE">Corinne E.</given-names>
            </name>
            <xref rid="A7" ref-type="aff">7</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Eng</surname>
              <given-names initials="K">Kenneth</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="FN2" ref-type="author-notes">‡</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Bareja</surname>
              <given-names initials="R">Rohan</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Han</surname>
              <given-names initials="T">Teng</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Liu</surname>
              <given-names initials="EM">Eric Minwei</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A8" ref-type="aff">8</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Palladino</surname>
              <given-names initials="A">Ann</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Di</surname>
              <given-names initials="W">Wei</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gao</surname>
              <given-names initials="D">Dong</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A9" ref-type="aff">9</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Abida</surname>
              <given-names initials="W">Wassim</given-names>
            </name>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Beg</surname>
              <given-names initials="S">Shaham</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Puca</surname>
              <given-names initials="L">Loredana</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="FN3" ref-type="author-notes">¶</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Meneses</surname>
              <given-names initials="M">Maximiliano</given-names>
            </name>
            <xref rid="A11" ref-type="aff">11</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>De Stanchina</surname>
              <given-names initials="E">Elisa</given-names>
            </name>
            <xref rid="A11" ref-type="aff">11</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Berger</surname>
              <given-names initials="MF">Michael F.</given-names>
            </name>
            <xref rid="A10" ref-type="aff">10</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Gopalan</surname>
              <given-names initials="A">Anuradha</given-names>
            </name>
            <xref rid="A12" ref-type="aff">12</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Dow</surname>
              <given-names initials="LE">Lukas E.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A13" ref-type="aff">13</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Mosquera</surname>
              <given-names initials="JM">Juan Miguel</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="A14" ref-type="aff">14</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Beltran</surname>
              <given-names initials="H">Himisha</given-names>
            </name>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="A15" ref-type="aff">15</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sternberg</surname>
              <given-names initials="CN">Cora N.</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A4" ref-type="aff">4</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chi</surname>
              <given-names initials="P">Ping</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A10" ref-type="aff">10</xref>
            <xref rid="A13" ref-type="aff">13</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Scher</surname>
              <given-names initials="HI">Howard I.</given-names>
            </name>
            <xref rid="A10" ref-type="aff">10</xref>
            <xref rid="A16" ref-type="aff">16</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Sboner</surname>
              <given-names initials="A">Andrea</given-names>
            </name>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="A14" ref-type="aff">14</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Chen</surname>
              <given-names initials="Y">Yu</given-names>
            </name>
            <xref rid="A5" ref-type="aff">5</xref>
            <xref rid="A10" ref-type="aff">10</xref>
            <xref rid="A13" ref-type="aff">13</xref>
            <xref rid="CR1" ref-type="corresp">†</xref>
          </contrib>
          <contrib contrib-type="author">
            <name name-style="western">
              <surname>Khurana</surname>
              <given-names initials="E">Ekta</given-names>
            </name>
            <xref rid="A1" ref-type="aff">1</xref>
            <xref rid="A2" ref-type="aff">2</xref>
            <xref rid="A3" ref-type="aff">3</xref>
            <xref rid="A4" ref-type="aff">4</xref>
            <xref rid="CR1" ref-type="corresp">†</xref>
          </contrib>
        </contrib-group>
        <aff id="A1"><label>1</label>Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA.</aff>
        <aff id="A2"><label>2</label>Institute for Computational Biomedicine, Weill Cornell Medical College, New York, NY 10021, USA.</aff>
        <aff id="A3"><label>3</label>Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10021, USA.</aff>
        <aff id="A4"><label>4</label>Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021 USA.</aff>
        <aff id="A5"><label>5</label>Human Oncology and Pathogenesis Program, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <aff id="A6"><label>6</label>State Key Laboratory of Reproductive Medicine, Urology department, the First Affiliated Hospital of Nanjing Medical University, Nanjing 211116, China.</aff>
        <aff id="A7"><label>7</label>Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <aff id="A8"><label>8</label>Computational Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA</aff>
        <aff id="A9"><label>9</label>State Key Laboratory of Cell Biology, Shanghai Key Laboratory of Molecular Andrology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai 200031, China</aff>
        <aff id="A10"><label>10</label>Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <aff id="A11"><label>11</label>Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <aff id="A12"><label>12</label>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <aff id="A13"><label>13</label>Department of Medicine, Weill Cornell Medical College and New York-Presbyterian Hospital, New York, NY 10065, USA.</aff>
        <aff id="A14"><label>14</label>Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY 10065, USA.</aff>
        <aff id="A15"><label>15</label>Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, USA.</aff>
        <aff id="A16"><label>16</label>Biomarker Development Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.</aff>
        <author-notes>
          <fn fn-type="current-aff" id="FN1">
            <label>#</label>
            <p id="P1">Current affiliation: AbbVie Cambridge Research Center, Cambridge, MA 02139, USA.</p>
          </fn>
          <fn fn-type="current-aff" id="FN2">
            <label>‡</label>
            <p id="P2">Current affiliation: Illumina Inc., San Diego, CA 92122, USA.</p>
          </fn>
          <fn fn-type="current-aff" id="FN3">
            <label>¶</label>
            <p id="P3">Current affiliation: Loxo Oncology at Lilly, New York, NY 10016, USA.</p>
          </fn>
          <fn fn-type="con" id="FN4">
            <label>*</label>
            <p id="P4">Co-first authors</p>
          </fn>
          <fn fn-type="con" id="FN5">
            <p id="P5"><bold>Author contributions:</bold> F.T., Y.C. and E.K. conceived of and designed the project. F.T., D.X., C.K.W., Y.C. and E.K. wrote the manuscript with the help of all authors. F.T., S.W, C.J.L, W.D, D.G, W.A, A.G, M.F.B, P.C, H.I.S and Y.C. performed or supervised the derivation, maintenance and characterization of the ten new organoids. F.T., J.P. and C.H. performed sample processing and ATAC-seq library construction. F.T., C.K.W. and S.C. performed functional validation experiments. H.T. constructed shRNA knockdown vectors with supervision from L.E.D. F.T. and D.X. performed the majority of bioinformatic analyses. K.E. performed whole exome sequencing data analysis for WCM organoids. R.H. provided bam files for WCM patient cohorts RNA-seq data. E.M.L. assisted with SU2C cohort analysis. A.M.F. assisted with gene expression analysis. A.P. assisted with the collection of organoids and cell lines SNV and CNV data. L.P. and H.B. provided WCM organoids. S.B., L.P., J.M.M, H.B., C.N.S. and A.S. collected and organized the WCM patient information and provided the sequencing data. M.M. and E.D.S. assisted with the PDX models. Y.C. and E.K. supervised the study.</p>
          </fn>
          <corresp id="CR1"><label>†</label>Corresponding authors. Email: <email>ekk2003@med.cornell.edu</email> (E.K.); <email>cheny1@mskcc.org</email> (Y.C.)</corresp>
          <fn fn-type="COI-statement" id="FN6">
            <p id="P64"><bold>Competing interests:</bold> Y.C. holds interest and receives royalties from ORIC pharmaceuticals.</p>
            <p id="P65">C.N.S. Disclosures: Pfizer, Merck, AstraZeneca, Astellas Pharma, Bayer, Bristol Myers Squibb, Genzyme, Gilead, Incyte, Impact Pharma, Merck, Medscape, MSD, Pfizer, Roche, UroToday. L.E.D. is an advisory board member and holds equity in Mirimus Inc.. L.E.D. has consulted on gene editing and knockdown technologies for Volastra Therapeutics, Frazier Healthcare, FogPharma, and Revolution Medicines. F.T is an employee at AbbVie, L.P. is an employee at Loxo Oncology at Lilly and K.E. is an employee at Illumina. This work was completed prior to their employment at industry. They are acting on their own, and these endeavors are not in any manner affiliated with their current affiliations.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="ppub">
          <day>27</day>
          <month>5</month>
          <year>2022</year>
        </pub-date>
        <pub-date pub-type="epub">
          <day>27</day>
          <month>5</month>
          <year>2022</year>
        </pub-date>
        <volume>376</volume>
        <issue>6596</issue>
        <issue-id pub-id-type="pmc-issue-id">412745</issue-id>
        <fpage>eabe1505</fpage>
        <lpage>eabe1505</lpage>
        <pub-history>
          <event event-type="nihms-submitted">
            <date>
              <day>13</day>
              <month>07</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-release">
            <date>
              <day>20</day>
              <month>07</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>20</day>
              <month>07</month>
              <year>2022</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2024-06-13 14:25:16.320">
              <day>13</day>
              <month>06</month>
              <year>2024</year>
            </date>
          </event>
        </pub-history>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1818940.pdf"/>
        <abstract id="ABS1">
          <p id="P6">In castration-resistant prostate cancer (CRPC), the loss of androgen receptor (AR)-dependence leads to clinically aggressive tumors with few therapeutic options. We used ATAC-seq, RNA-seq, and DNA sequencing to investigate 22 organoids, 6 patient-derived xenografts, and 12 cell lines. We identified the well-characterized AR-dependent and neuroendocrine subtypes and two AR-negative/low groups. These include a Wnt-dependent subtype, and a stem cell-like (SCL) subtype driven by the Activator protein-1 (AP-1) transcription factors. Transcriptomic signatures were used to classify 366 patients, showing SCL subtype as the second most common group of CRPC after AR-dependent. Our data suggest AP-1 interacts with the YAP/TAZ and TEAD proteins to maintain subtype-specific chromatin accessibility and transcriptomic landscapes in this group. Together, this molecular classification reveals drug targets and can potentially guide therapeutic decisions.</p>
        </abstract>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
    </front>
  </article>
</pmc-articleset>
